Status:

COMPLETED

Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis

Lead Sponsor:

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Collaborating Sponsors:

Carlos III Health Institute

Hospital Universitario Virgen de la Arrixaca

Conditions:

Pseudoarthrosis

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The purpose of this clinical trial is to check the non-inferiority and lower morbidity of the use of bone marrow mononuclear cells seeded onto a porous matrix of calcium phosphate, for the consolidati...

Detailed Description

An estimated 10% of closed fractures and between 35-45% in cases of open fractures, are at risk of developing a delay in the process of consolidation or a complete failure of it (pseudoarthrosis) depe...

Eligibility Criteria

Inclusion

  • Pseudarthrosis of tibia established any cause with at least 9 months.
  • The pseudarthrosis is not to show signs of healing in the last 3 months.
  • The pseudarthrosis subsidiary should not be solely osteosynthesis treatment.
  • Age between 18 and 75 years.
  • Serology Human Immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative.
  • Negative pregnancy test in women of childbearing age.
  • Patient sufficient guarantees of adherence to protocol.
  • Signature written informed consent before a witness

Exclusion

  • Systemic infection.
  • Septic pseudoarthrosis.
  • Insufficient skin coverage at the site of nonunion.
  • Vascular insufficiency in the affected limb.
  • Pathological fracture.
  • Concomitant psychiatric or neurological disease.
  • Concurrent or prior malignancy treated with chemotherapy over a period of less than 1 year.
  • Concomitant severe disease not well controlled.
  • Inclusion in other clinical trials.
  • Inability to understand the informed consent

Key Trial Info

Start Date :

April 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT01813188

Start Date

April 1 2011

End Date

June 1 2014

Last Update

March 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital UniversitarioVirgen de la Arrixaca

El Palmar, Murcia, Spain, 30120